Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market

Australian milk powder wholesalers Jatenergy has signed an agreement with Chinese tech group – HIT Crown, granting access to the Chinese medicine market.

HIT Crown manages the online Medicine E-Business and specialises in cloud-based servers in the Chinese market. China Golden, services over one million pharmaceutical companies, hospitals and clinics in the Chinese market.

This Memorandum of Understanding grants JAT access to sell its milk formulas Neurio and Golden Koala through HIT Crown’s online network.

Jatenergy Managing Director Wilton Yao says the agreement provides a framework to service the Chinese middle-class household.

“We are very comfortable about the future sales of our in-house brands as more and more Chinese and overseas distributors express their wish to work together with Jatenergy to promote our products through strategic partnerships,” he said.

Please see the announcement attached

JAT by the numbers
More From The Market Herald
(ASX:ATH) -

" Alterity Therapeutics (ASX:ATH) expands clinical development program

Alterity Therapeutics (ATH) is expanding the phase two clinical development program for its lead asset ATH434 in patients with Multiple System Atrophy (MSA).
Althea Group (ASX:AGH) - CEO, Joshua Fegan

" Althea Group (ASX:AGH) hits new high in sales receipts

Althea Group (AGH) brought in a new high of $4.5 million in customer receipts over the recently completed September quarter.
Singular Health Group (ASX:SHG) - Chief Operating Officer, James Hill

" Singular Health (ASX:SHG) collaborates with CSIRO and Osteopore (ASX:OSX)

Singular Health Group (SHG) will collaborate with CSIRO and Osteopore (OSX) for an artificial intelligence (AI) based tool to make patient-specific 3D cranial
ImpediMed (ASX:IPD) - MD and CEO, Richard Carreon

" ImpediMed (ASX:IPD) completes lymphoedema prevention trial

ImpediMed (IPD) has rounded off its PREVENT trial, successfully meeting its primary end point.